Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

CDC Ebola Expert Tim Uyeki, MD, MPH, Offers Ebola Management and Safety Information

By Jon Mark Hirshon, MD, PhD, FACEP | on November 13, 2014 | 2 Comments
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Ebola

A person who presents with sudden onset of fever, cough, sore throat, and nasal congestion or rhinorrhea is likely to have influenza or other common respiratory viral diseases. This is especially true if household contacts are sick with similar respiratory illness, so ask about similar illness in family members, household contacts, and close contacts. As we approach the fall/winter respiratory virus season, clinicians should not suspect Ebola virus disease in persons with fever who have not traveled recently to West Africa or those who do not have a history of direct contact with the bodily fluids of a person who was sick or recently died of suspected or confirmed Ebola virus disease. Of course, we do not want to miss any imported cases of Ebola virus disease. However, even though there will likely be some medically evacuated patients and rare sporadic imported cases of Ebola virus disease in the United States over the next year, such cases will remain rare here.

You Might Also Like
  • CDC Resources on Ebola Outbreak
  • ACEP14 Ebola Courses Available to All Beginning Friday
  • Are You Ready for Ebola?
Explore This Issue
ACEP Now: Vol 33 – No 11 – November 2014

Also, be sure to tell you readers that there is much more information on the CDC website. This is the best single location for updated information about Ebola virus disease and other infectious diseases.

JMH: Thank you again for taking the time to speak with me. I am sure that our members will appreciate your comments and recommendations.


Dr. Hirshon is associate professor of emergency medicine at the University of Maryland School of Medicine in Baltimore and a member of the ACEP Board of Directors.

Take Advantage of Free Ebola Courses from ACEP14

ACEP is offering a free education opportunity called “ACEP14 Ebola Courses,” which includes live recordings of the three Ebola talks presented to packed houses at ACEP14. The talks have been repurposed as online CME courses so everyone who cares for patients in emergency departments—not just ACEP members—can watch them free. Each course has a pretest, an audio and slide presentation of the lecture, and a post-test. Each course also is approved for AMA PRA Category 1 Credit.™

The three courses are:

Inside the Hot Zone: Highly Infectious Pathogens in the ED
Which pathogens are most likely to be encountered in the emergency department? Which ones present the greatest risk for health care providers and other personnel? This case-based review includes a discussion of appropriate barrier precautions, personal protective equipment, and department and hospital-based infectious disease transmission precautions.

Ebola: Hemorrhagic Fever and the U.S. Experience
Now that Ebola virus disease has made its way to the United States, everyone who cares for patients in emergency departments must learn more about the risk factors for exposure to the Ebola virus, the clinical features, and considerations for evaluation and management of patients with suspected or confirmed Ebola virus disease. This course highlights the most recent recommendations for out-of-hospital and emergency department health care workers.

Pages: 1 2 3 4 | Single Page

Topics: CDCCenters for Disease Control and PreventionCritical CareEbolaEmergency MedicineEmergency PhysicianFluHealth Care Worker SafetyInfectious DiseaseInfluenzaPatient SafetyPersonal Protective EquipmentPublic HealthRespiratory DiseaseTravelVirus

Related

  • Opinion: Physicians Must Reduce Plastic Waste

    December 4, 2025 - 0 Comment
  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Q&A with ACEP President L. Anthony Cirillo

    November 5, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

2 Responses to “CDC Ebola Expert Tim Uyeki, MD, MPH, Offers Ebola Management and Safety Information”

  1. September 22, 2015

    Ebola Drug Gets FDA Fast Track Status - ACEP Now Reply

    […] said on Sept. 17 that the U.S. Food and Drug Administration (FDA) granted fast track status to its Ebola drug ZMapp. The FDA grants the status to drugs intended to treat serious conditions that have few […]

  2. October 15, 2015

    Johnson & Johnson Begins Ebola Vaccine Trials in Sierra Leone - ACEP Now Reply

    […] & Johnson (J&J) has begun a clinical trial of a two-shot Ebola vaccine in Sierra Leone, underlining its determination to push ahead with development, even as the […]

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603